Share on StockTwits

Dentsply International (NASDAQ:XRAY) Director Michael C. Alfano sold 2,764 shares of Dentsply International stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $47.25, for a total value of $130,599.00. Following the transaction, the director now directly owns 7,207 shares of the company’s stock, valued at approximately $340,531. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Dentsply International (NASDAQ:XRAY) traded up 0.13% on Monday, hitting $47.35. 563,050 shares of the company’s stock traded hands. Dentsply International has a 52 week low of $39.90 and a 52 week high of $50.99. The stock has a 50-day moving average of $45.69 and a 200-day moving average of $46.60. The company has a market cap of $6.714 billion and a price-to-earnings ratio of 21.79.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.59 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.56 by $0.03. The company had revenue of $730.10 million for the quarter, compared to the consensus estimate of $747.27 million. During the same quarter in the prior year, the company posted $0.52 earnings per share. The company’s quarterly revenue was down .3% on a year-over-year basis. On average, analysts predict that Dentsply International will post $2.52 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.0663 per share. This represents a $0.27 annualized dividend and a dividend yield of 0.56%. The ex-dividend date is Wednesday, June 25th.

A number of analysts have recently weighed in on XRAY shares. Analysts at Barrington Research upgraded shares of Dentsply International from a “market perform” rating to an “outperform” rating in a research note on Friday, May 16th. Analysts at Zacks reiterated a “neutral” rating on shares of Dentsply International in a research note on Wednesday, May 7th. They now have a $48.00 price target on the stock. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $50.75.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.